PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancerQiang Wang(General Hospital of Jinan Military Command), Jingwang Bi(General Hospital of Jinan Military Command)Cell Death and DiseaseJuly 3, 201810.1038/s41419-018-0776-6Cited by 150SaveCiteExport RISWatch citationsRelated PapersTamoxifen enhances stemness and promotes metastasis of ERα36+ breast cancer by upregulating ALDH1A1 in cancer cells|Cell Research|2018|130Involvement of GluR2 up-regulation in neuroprotection by electroacupuncture pretreatment via cannabinoid CB1 receptor in mice|Scientific Reports|2015|49